Reuters reports that India will begin human trials of a new vaccine against the virus in January.
India has over 5.1 million people living with HIV/AIDS, the world's second largest HIV population, and experts say the number could quadruple by 2010:
Human trials of vaccines against different strains of the virus are already being conducted in the United States, Europe, Africa and South America. The Indian trial will focus on sub-type C of the virus, the most common in the country.
[. . .]
The first phase of testing of the vaccine, named Adeno Associated Virus based HIV sub-type C, will be conducted on about 30 adult volunteers, Paranjape said.
The NARI scientists will monitor the volunteers over a period of one year to test for side-effects and the immune system's response to the vaccine.
Comments